NCT04082741View on ClinicalTrials.gov

A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 18, 2019

Primary Completion Date

September 12, 2019

Study Completion Date

September 12, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986318

Specified dose on specified days

OTHER

Placebo

Placebo Matching BMS-986318

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY